Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : INCE - Intercell info??? -- Ignore unavailable to you. Want to Upgrade?

To: Cavalry who wrote (2835)	7/26/1998 8:26:00 PM
From: Juli	Read Replies (1) \| Respond to of 3358

I don't believe INCE will be hurt any more than NPCT will. INCE still owns 74% at this point. The total number of shares is almost 12 million, so INCE's value based on NPCT share price is much more than you stated. It is actually priced at more than a 90% discount to NPCT. If INCE technology works and if Paul and Gil can get NPCT on its feet, then INCE will be a far bigger winner than NPCT from here. If they cannot make it work, then both lose. There will be share dilution and INCE will own a smaller % of NPCT, but so will you. The issue here is with the past history of Paul Metzinger. Old INCE shareholders are skeptical because they have been through a lot. Only time will tell.